The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Clone

English version České info

Escherichia coli ST131 is a globally disseminated, multidrug resistant clone responsible for a high proportion of urinary tract and bloodstream infections. The rapid emergence and successful spread of E. coli ST131 is strongly associated with antibiotic resistance; however, this phenotype alone is unlikely to explain its dominance amongst multidrug resistant uropathogens circulating worldwide in hospitals and the community. Thus, a greater understanding of the molecular mechanisms that underpin the fitness of E. coli ST131 is required. In this study, we employed hyper-saturated transposon mutagenesis in combination with multiplexed transposon directed insertion-site sequencing to define the essential genes required for in vitro growth and the serum resistome (i.e. genes required for resistance to human serum) of E. coli EC958, a representative of the predominant E. coli ST131 clonal lineage. We identified 315 essential genes in E. coli EC958, 231 (73%) of which were also essential in E. coli K-12. The serum resistome comprised 56 genes, the majority of which encode membrane proteins or factors involved in lipopolysaccharide (LPS) biosynthesis. Targeted mutagenesis confirmed a role in serum resistance for 46 (82%) of these genes. The murein lipoprotein Lpp, along with two lipid A-core biosynthesis enzymes WaaP and WaaG, were most strongly associated with serum resistance. While LPS was the main resistance mechanism defined for E. coli EC958 in serum, the enterobacterial common antigen and colanic acid also impacted on this phenotype. Our analysis also identified a novel function for two genes, hyxA and hyxR, as minor regulators of O-antigen chain length. This study offers novel insight into the genetic make-up of E. coli ST131, and provides a framework for future research on E. coli and other Gram-negative pathogens to define their essential gene repertoire and to dissect the molecular mechanisms that enable them to survive in the bloodstream and cause disease.

Vyšlo v časopise: The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Clone. PLoS Genet 9(10): e32767. doi:10.1371/journal.pgen.1003834
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003834

Souhrn

Zdroje

1. Nicolas-ChanoineMH, BlancoJ, Leflon-GuiboutV, DemartyR, AlonsoMP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273–281.

2. PitoutJD, GregsonDB, CampbellL, LauplandKB (2009) Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53: 2846–2851.

3. JohnsonJR, JohnstonB, ClabotsC, KuskowskiMA, CastanheiraM (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51: 286–294.

4. PeiranoG, PitoutJD (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35: 316–321.

5. SidjabatHE, DerringtonP, NimmoGR, PatersonDL (2010) Escherichia coli ST131 producing CTX-M-15 in Australia. J Antimicrob Chemother 65: 1301–1303.

6. RogersBA, SidjabatHE, PatersonDL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1–14.

7. EnderPT, GajananaD, JohnstonB, ClabotsC, TamarkinFJ, et al. (2009) Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol 47: 3780–3782.

8. JohnsonJR, AndersonJT, ClabotsC, JohnstonB, CooperstockM (2010) Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J 29: 473–475.

9. CoqueTM, NovaisA, CarattoliA, PoirelL, PitoutJ, et al. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14: 195–200.

10. JohnsonJR, MenardM, JohnstonB, KuskowskiMA, NicholK, et al. (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53: 2733–2739.

11. JohnsonJR, TchesnokovaV, JohnstonB, ClabotsC, RobertsPL, et al. (2013) Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli. J Infect Dis 207: 919–928.

12. PeiranoG, SchreckenbergerPC, PitoutJD (2011) Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55: 2986–2988.

13. MorrisD, BoyleF, LuddenC, CondonI, HaleJ, et al. (2011) Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 55: 4935–4936.

14. MorrisD, McGarryE, CotterM, PassetV, LynchM, et al. (2012) Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 56: 4030–4031.

15. TotsikaM, MorielDG, IdrisA, RogersBA, WurpelDJ, et al. (2012) Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 13: 1386–1399.

16. UlettGC, TotsikaM, SchaaleK, CareyAJ, SweetMJ, et al. (2013) Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16: 100–107.

17. ClermontO, LavollayM, VimontS, DeschampsC, ForestierC, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024–1028.

18. JohnsonJR, PorterSB, ZhanelG, KuskowskiMA, DenamurE (2012) Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 80: 1554–1562.

19. LavigneJP, VergunstAC, GoretL, SottoA, CombescureC, et al. (2012) Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7: e34294.

20. GibreelTM, DodgsonAR, CheesbroughJ, BoltonFJ, FoxAJ, et al. (2012) High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J Clin Microbiol 50: 3202–3207.

21. VimontS, BoydA, BleibtreuA, BensM, GoujonJM, et al. (2012) The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7: e46547.

22. TotsikaM, BeatsonSA, SarkarS, PhanMD, PettyNK, et al. (2011) Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms. PLoS One 6: e26578.

23. LauSH, KaufmannME, LivermoreDM, WoodfordN, WillshawGA, et al. (2008) UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 62: 1241–1244.

24. TotsikaM, KostakiotiM, HannanTJ, UptonM, BeatsonSA, et al. (2013) A FimH Inhibitor Prevents Acute Bladder Infection and Treats Chronic Cystitis Caused by Multidrug-Resistant Uropathogenic Escherichia coli ST131. J Infect Dis 208(6): 921–8.

25. FloydRV, UptonM, HultgrenSJ, WrayS, BurdygaTV, et al. (2012) Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis 206: 1589–1596.

26. McCabeWR, KaijserB, OllingS, UwaydahM, HansonLA (1978) Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis 138: 33–41.

27. MartínezJL, CercenadoE, Pérez-DíazJC, BaqueroF (1986) Multifactorial determination of systemic invasivity in Escherichia coli. FEMS Microbiology Letters 37: 259–261.

28. JacobsonSH, ÖStensonC-G, TullusK, BraunerA (1992) Serum resistance in Escherichia coli strains causing acute pyelonephritis and bacteraemia. APMIS 100: 147–153.

29. OpalS, CrossA, GemskiP (1982) K antigen and serum sensitivity of rough Escherichia coli. Infect Immun 37: 956–960.

30. FeingoldDS (1969) The serum bactericidal reaction. IV. Phenotypic conversion of Escherichia coli from serum-resistance to serum-sensitivity by diphenylamine. J Infect Dis 120: 437–444.

31. GemskiP, CrossAS, SadoffJC (1980) K1 antigen-associated resistance to the bactericidal activity of serum. FEMS Microbiology Letters 9: 193–197.

32. StawskiG, NielsenL, ØRskovF, ØRskovIDA (1990) Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. APMIS 98: 828–838.

33. CrossAS, KimKS, WrightDC, SadoffJC, GemskiP (1986) Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J Infect Dis 154: 497–503.

34. BurnsSM, HullSI (1998) Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 66: 4244–4253.

35. PoratR, MosseriR, KaplanE, JohnsMA, ShiboletS (1992) Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum. J Infect Dis 165: 953–956.

36. WeiserJN, GotschlichEC (1991) Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 59: 2252–2258.

37. MollA, ManningPA, TimmisKN (1980) Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli. Infect Immun 28: 359–367.

38. MontenegroMA, Bitter-SuermannD, TimmisJK, AgueroME, CabelloFC, et al. (1985) traT gene sequences, serum resistance and pathogenicity-related factors in clinical isolates of Escherichia coli and other gram-negative bacteria. J Gen Microbiol 131: 1511–1521.

39. SmithHW (1974) A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated, or identical, with colicine V. J Gen Microbiol 83: 95–111.

40. BarondessJJ, BeckwithJ (1995) bor gene of phage lambda, involved in serum resistance, encodes a widely conserved outer membrane lipoprotein. J Bacteriol 177: 1247–1253.

41. ChristenB, AbeliukE, CollierJM, KalogerakiVS, PassarelliB, et al. (2011) The essential genome of a bacterium. Mol Syst Biol 7: 528.

42. LangridgeGC, PhanMD, TurnerDJ, PerkinsTT, PartsL, et al. (2009) Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res 19: 2308–2316.

43. GoodmanAL, McNultyNP, ZhaoY, LeipD, MitraRD, et al. (2009) Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6: 279–289.

44. GawronskiJD, WongSM, GiannoukosG, WardDV, AkerleyBJ (2009) Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A 106: 16422–16427.

45. van OpijnenT, BodiKL, CamilliA (2009) Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 6: 767–772.

46. BarquistL, LangridgeGC, TurnerDJ, PhanMD, TurnerAK, et al. (2013) A comparison of dense transposon insertion libraries in the Salmonella serovars Typhi and Typhimurium. Nucleic Acids Res 41(8): 4549–64.

47. DatsenkoKA, WannerBL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645.

48. RobinsonMD, McCarthyDJ, SmythGK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139–140.

49. WhangHY, NeterE (1973) Production of common enterobacterial antigen by members of the family Enterobacteriaceae. Experientia 29: 96–97.

50. MakelaPH, MayerH (1976) Enterobacterial common antigen. Bacteriol Rev 40: 591–632.

51. BeutinL, ManningPA, AchtmanM, WillettsN (1981) sfrA and sfrB products of Escherichia coli K-12 are transcriptional control factors. J Bacteriol 145: 840–844.

52. BaileyMJ, HughesC, KoronakisV (1996) Increased distal gene transcription by the elongation factor RfaH, a specialized homologue of NusG. Mol Microbiol 22: 729–737.

53. NagyG, DobrindtU, SchneiderG, KhanAS, HackerJ, et al. (2002) Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. Infect Immun 70: 4406–4413.

54. NagyG, DobrindtU, GrozdanovL, HackerJ, EmodyL (2005) Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli. FEMS Microbiol Lett 244: 173–180.

55. WangQ, WangS, BeutinL, CaoB, FengL, et al. (2010) Development of a DNA microarray for detection and serotyping of enterotoxigenic Escherichia coli. J Clin Microbiol 48: 2066–2074.

56. StevensonG, NealB, LiuD, HobbsM, PackerNH, et al. (1994) Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. J Bacteriol 176: 4144–4156.

57. KenneL, LindbergB, MaddenJK, LindbergAA, GemskiPJr (1983) Structural studies of the Escherichia coli O-antigen 25. Carbohydr Res 122: 249–256.

58. FundinJ, WeintraubA, XuJ-G, WidmalmG (2003) NMR analysis of the O-antigen polysaccharide from Escherichia coli strain F171. Magnetic Resonance in Chemistry 41: 202–205.

59. LiuD, ColeRA, ReevesPR (1996) An O-antigen processing function for Wzx (RfbX): a promising candidate for O-unit flippase. J Bacteriol 178: 2102–2107.

60. HanX, Dorsey-OrestoA, MalikM, WangJY, DrlicaK, et al. (2010) Escherichia coli genes that reduce the lethal effects of stress. BMC Microbiol 10: 35.

61. AllenMJ, WhiteGF, MorbyAP (2006) The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 152: 989–1000.

62. FrancoAV, LiuD, ReevesPR (1998) The wzz (cld) protein in Escherichia coli: amino acid sequence variation determines O-antigen chain length specificity. J Bacteriol 180: 2670–2675.

63. StenutzR, WeintraubA, WidmalmG (2006) The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30: 382–403.

64. LundborgM, ModhukurV, WidmalmG (2010) Glycosyltransferase functions of E. coli O-antigens. Glycobiology 20: 366–368.

65. SchnaitmanCA, KlenaJD (1993) Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 57: 655–682.

66. RaetzCR, WhitfieldC (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635–700.

67. MaroldaCL, TatarLD, AlaimoC, AebiM, ValvanoMA (2006) Interplay of the Wzx translocase and the corresponding polymerase and chain length regulator proteins in the translocation and periplasmic assembly of lipopolysaccharide o antigen. J Bacteriol 188: 5124–5135.

68. AlexanderDC, ValvanoMA (1994) Role of the rfe gene in the biosynthesis of the Escherichia coli O7-specific lipopolysaccharide and other O-specific polysaccharides containing N-acetylglucosamine. J Bacteriol 176: 7079–7084.

69. DanesePN, PrattLA, KolterR (2000) Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol 182: 3593–3596.

70. BatemanSL, SeedPC (2012) Epigenetic regulation of the nitrosative stress response and intracellular macrophage survival by extraintestinal pathogenic Escherichia coli. Mol Microbiol 83: 908–925.

71. AllsoppLP, BeloinC, UlettGC, ValleJ, TotsikaM, et al. (2012) Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun 80: 321–332.

72. KeselerIM, Collado-VidesJ, Santos-ZavaletaA, Peralta-GilM, Gama-CastroS, et al. (2011) EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Res 39: D583–590.

73. YemDW, WuHC (1978) Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein. J Bacteriol 133: 1419–1426.

74. Vadillo-RodriguezV, SchoolingSR, DutcherJR (2009) In situ characterization of differences in the viscoelastic response of individual gram-negative and gram-positive bacterial cells. J Bacteriol 191: 5518–5525.

75. CascalesE, LloubesR, SturgisJN (2001) The TolQ-TolR proteins energize TolA and share homologies with the flagellar motor proteins MotA-MotB. Mol Microbiol 42: 795–807.

76. WalburgerA, LazdunskiC, CordaY (2002) The Tol/Pal system function requires an interaction between the C-terminal domain of TolA and the N-terminal domain of TolB. Mol Microbiol 44: 695–708.

77. OnufrykC, CrouchML, FangFC, GrossCA (2005) Characterization of six lipoproteins in the sigmaE regulon. J Bacteriol 187: 4552–4561.

78. NikaidoH, VaaraM (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49: 1–32.

79. YanA, GuanZ, RaetzCR (2007) An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli. J Biol Chem 282: 36077–36089.

80. TrentMS, RibeiroAA, DoerrlerWT, LinS, CotterRJ, et al. (2001) Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli: structural characterization and transfer to lipid A in the periplasm. J Biol Chem 276: 43132–43144.

81. RaetzCR, ReynoldsCM, TrentMS, BishopRE (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76: 295–329.

82. FrickDN, TownsendBD, BessmanMJ (1995) A novel GDP-mannose mannosyl hydrolase shares homology with the MutT family of enzymes. J Biol Chem 270: 24086–24091.

83. FraenkelDG, LevisohnSR (1967) Glucose and gluconate metabolism in an Escherichia coli mutant lacking phosphoglucose isomerase. J Bacteriol 93: 1571–1578.

84. FraenkelDG, HoreckerBL (1965) Fructose-1, 6-diphosphatase and acid hexose phosphatase of Escherichia coli. J Bacteriol 90: 837–842.

85. PrasadaraoNV, BlomAM, VilloutreixBO, LinsanganLC (2002) A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 169: 6352–6360.

86. HellmanJ, LoisellePM, TehanMM, AllaireJE, BoyleLA, et al. (2000) Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun 68: 2566–2572.

87. KircherM, HeynP, KelsoJ (2011) Addressing challenges in the production and analysis of illumina sequencing data. BMC Genomics 12: 382.

88. KruegerF, AndrewsSR, OsborneCS (2011) Large scale loss of data in low-diversity illumina sequencing libraries can be recovered by deferred cluster calling. PLoS One 6: e16607.

89. CrimminsGT, MohammadiS, GreenER, BergmanMA, IsbergRR, et al. (2012) Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog 8: e1002828.

90. GallagherLA, ShendureJ, ManoilC (2011) Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq. MBio 2: e00315–00310.

91. van OpijnenT, CamilliA (2013) Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. Nat Rev Microbiol 11: 435–442.

92. BarquistL, BoinettCJ, CainAK (2013) Approaches to querying bacterial genomes with transposon-insertion sequencing. RNA Biol 10: 1161–9.

93. KooninEV (2003) Comparative genomics, minimal gene-sets and the last universal common ancestor. Nat Rev Microbiol 1: 127–136.

94. FangG, RochaE, DanchinA (2005) How essential are nonessential genes? Mol Biol Evol 22: 2147–2156.

95. GerdesS, EdwardsR, KubalM, FonsteinM, StevensR, et al. (2006) Essential genes on metabolic maps. Curr Opin Biotechnol 17: 448–456.

96. GerdesSY, ScholleMD, CampbellJW, BalazsiG, RavaszE, et al. (2003) Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 185: 5673–5684.

97. BabaT, AraT, HasegawaM, TakaiY, OkumuraY, et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006 0008.

98. TaylorPW (1975) Genetical studies of serum resistance in Escherichia coli. J Gen Microbiol 89: 57–66.

99. RussoTA, SharmaG, BrownCR, CampagnariAA (1995) Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect Immun 63: 1263–1269.

100. BucklesEL, WangX, LaneMC, LockatellCV, JohnsonDE, et al. (2009) Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis 199: 1689–1697.

101. LeyingH, SuerbaumS, KrollHP, StahlD, OpferkuchW (1990) The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect Immun 58: 222–227.

102. WhitfieldC (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75: 39–68.

103. StevensonG, AndrianopoulosK, HobbsM, ReevesPR (1996) Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J Bacteriol 178: 4885–4893.

104. WhiteRJ (1968) Control of amino sugar metabolism in Escherichia coli and isolation of mutants unable to degrade amino sugars. Biochem J 106: 847–858.

105. ParkJT, UeharaT (2008) How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev 72: 211–227.

106. AdhyaS, SchwartzM (1971) Phosphoglucomutase mutants of Escherichia coli K-12. J Bacteriol 108: 621–626.

107. InoueT, ShingakiR, HiroseS, WakiK, MoriH, et al. (2007) Genome-wide screening of genes required for swarming motility in Escherichia coli K-12. J Bacteriol 189: 950–957.

108. LuM, KlecknerN (1994) Molecular cloning and characterization of the pgm gene encoding phosphoglucomutase of Escherichia coli. J Bacteriol 176: 5847–5851.

109. FreyPA (1996) The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J 10: 461–470.

110. WeissbornAC, LiuQ, RumleyMK, KennedyEP (1994) UTP: alpha-D-glucose-1-phosphate uridylyltransferase of Escherichia coli: isolation and DNA sequence of the galU gene and purification of the enzyme. J Bacteriol 176: 2611–2618.

111. LiH, RuanJ, DurbinR (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18: 1851–1858.

112. RutherfordK, ParkhillJ, CrookJ, HorsnellT, RiceP, et al. (2000) Artemis: sequence visualization and annotation. Bioinformatics 16: 944–945.

113. StothardP, WishartDS (2005) Circular genome visualization and exploration using CGView. Bioinformatics 21: 537–539.

114. SullivanMJ, PettyNK, BeatsonSA (2011) Easyfig: a genome comparison visualizer. Bioinformatics 27: 1009–1010.

115. RobinsonMD, OshlackA (2010) A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11: R25.

116. RobinsonMD, SmythGK (2008) Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9: 321–332.

117. RobinsonMD, SmythGK (2007) Moderated statistical tests for assessing differences in tag abundance. Bioinformatics 23: 2881–2887.

118. AllsoppLP, TotsikaM, TreeJJ, UlettGC, MabbettAN, et al. (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78: 1659–1669.

119. MartinezE, BartolomeB, de la CruzF (1988) pACYC184-derived cloning vectors containing the multiple cloning site and lacZ alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene 68: 159–162.

120. WiegandI, HilpertK, HancockRE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3: 163–175.

121. WestNP, JungnitzH, FitterJT, McArthurJD, GuzmanCA, et al. (2000) Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun 68: 4673–4680.

122. TsaiCM, FraschCE (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115–119.